According to Gufic Biosciences latest financial reports the cash on hand of GUFICBIO is $5.57M, an increase of 75.70% to 2022. At the end of 2022 company had $3.17M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $5.57M | 75.70% |
2022 | $3.17M | 101.63% |
2021 | $1.57M | 209.23% |
2020 | $508.09K | 16.39% |
2019 | $436.54K | - |